Old Web
English
Sign In
Acemap
>
authorDetail
>
Rong Shi
Rong Shi
Bristol-Myers Squibb
Pharmacology
Medicine
Keyhole limpet hemocyanin
Pharmacodynamics
Pharmacokinetics
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Application of Minimal Anticipated Biological Effect Level (MABEL) in Human Starting Dose Selection for Immunomodulatory Protein Therapeutics – Principles and Case Studies
2019
Haiqing Wang
Zheng Yang
Rong Shi
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti‐CD28 Domain Antibody Antagonist in Healthy Subjects
2017
The Journal of Clinical Pharmacology
Rong Shi
Marek Honczarenko
Sean Zhang
Catherine Fleener
Johanna Mora
Sun Ku Lee
Reena Wang
Xiaoni Liu
Diane Shevell
Zheng Yang
Haiqing Wang
Bindu Murthy
Show All
Source
Cite
Save
Citations (18)
Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699
2015
Journal of Pharmacology and Experimental Therapeutics
Zheng Yang
Hugh Wang
Theodora W. Salcedo
Suzanne J. Suchard
Jenny Xie
Lumelle A. Schneeweis
Catherine A. Fleener
J. D. Calore
Rong Shi
S. X. Y. Zhang
Rodrigues Ad
Bruce D. Car
Punit Marathe
Steven G. Nadler
Show All
Source
Cite
Save
Citations (11)
1